Lv21
190 积分 2024-12-13 加入
Once-weekly semaglutide 7·2 mg in adults with obesity and type 2 diabetes (STEP UP T2D): a randomised, controlled, phase 3b trial
1个月前
已完结
Tirzepatide did not impact metabolic adaptation in people with obesity, but increased fat oxidation
1个月前
已完结
Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight
1个月前
已完结
Amycretin, a novel, unimolecular GLP-1 and amylin receptor agonist administered subcutaneously: results from a phase 1b/2a randomised controlled study
1个月前
已完结
Once-Monthly Maridebart Cafraglutide for the Treatment of Obesity - A Phase 2 Trial
1个月前
已完结
Cagrilintide-Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes
1个月前
已完结
Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity
1个月前
已完结
Efficacy and safety of co-administered once-weekly cagrilintide 2·4 mg with once-weekly semaglutide 2·4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial
1个月前
已完结
The GIP receptor activates futile calcium cycling in white adipose tissue to increase energy expenditure and drive weight loss in mice
1个月前
已完结
GPR45 modulates Gαs at primary cilia of the paraventricular hypothalamus to control food intake
1个月前
已完结
皖公网安备34019202002308
